HealthKois has launched a new healthcare investment fund with a target of US$300 million, plus a green shoe option of US$100 million.

Announced on June 6, 2025, the fund will support early growth-stage healthcare enterprises in India.

It is led by the founding team of HealthQuad: Charles Janssen, Ajay Mahipal, and Dr. Pinak Shrikhande.

The fund plans to invest between US$7 million and US$25 million per company over the next four years.

Focus sectors include HealthTech, Life Sciences, MedTech, Healthcare Delivery, and Climate Health.

It will prioritize companies with scalable operations, measurable clinical outcomes, and sustainable infrastructure.

🔗 Source: HealthKois

🧠 Food for thought

1️⃣ India’s healthcare investment landscape is maturing with specialized funds amid surging market growth

HealthKois enters the market during a pivotal period for Indian healthcare investments, which reached $5-6 billion in 2024, nearly double pre-pandemic levels according to recent data 1.

The fund’s launch reflects a broader market trend where investors are establishing exclusive healthcare-focused funds to capitalize on India’s healthcare sector, which surpassed $370 billion in 2022 and is projected to reach over $610 billion by 2026 2.

The $7-25 million investment range targets the growth-stage funding gap that exists between early-stage venture capital and large private equity investments in India’s healthcare ecosystem.

This strategic positioning aligns with shifting investment priorities in Indian healthcare, where capital is increasingly flowing toward single-specialty providers, technology-enabled solutions, and scalable healthcare delivery models that can address accessibility challenges 1.

HealthKois’ focus on five specific subsectors (HealthTech, Life Sciences, MedTech, Healthcare Delivery, and Climate Health) reflects expert projections that consolidation in diagnostics, medical devices, and specialty care will drive the next wave of healthcare investments in India.

2️⃣ Post-pandemic healthcare investment thesis emphasizes dual returns and infrastructure resilience

HealthKois’ commitment to both financial returns and societal impact follows a documented shift in healthcare investment priorities after COVID-19, which exposed critical infrastructure gaps in India’s healthcare system.